Fig. 2
From: Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer
The expression of ENOs among different groups of BLCA patients based on clinical parameters. A–D Boxplots of ENO1 relative expression based on sample type, molecular subtype, cancer stage and lymph node metastasis. E–H Boxplots of ENO2 relative expression based on sample type, molecular subtype, cancer stage and lymph node metastasis. I–L Boxplots of ENO3 relative expression based on sample type, molecular subtype, cancer stage and lymph node metastasis. *p < 0.05, **p < 0.01, ***p < 0.001